PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Cancer Research and Treatment10.4143/crt.2015.25020164841264-1273Prognostic Factors for Risk Stratification of Patients with Recurrent or Metastatic Pancreatic Adenocarcinoma Who Were Treated with Gemcitabine-Based ChemotherapyInkeun Park, Seung Joon Choi, Young Saing Kim, Hee Kyung Ahn, Junshik Hong, Sun Jin Sym, Jinny Park, Eun Kyung Cho, Jae Hoon Lee, Yong Ju Shin, Dong Bok Shinhttp://e-crt.org/upload/pdf/crt-2015-250.pdf, http://e-crt.org/journal/view.php?doi=10.4143/crt.2015.250, http://www.e-crt.org/upload/pdf/crt-2015-250.pdf
Annals of Oncology10.1093/annonc/mdy432.054201829ix64Prognostic impact of progression type by RECIST criteria in patients with metastatic pancreatic cancer who received first-line gemcitabine-based chemotherapyJ. Lee, M.A. Lee, I.-H. Kimhttps://api.elsevier.com/content/article/PII:S0923753419431694?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0923753419431694?httpAccept=text/plain, http://academic.oup.com/annonc/article-pdf/29/suppl_9/mdy432.054/26698986/mdy432.054.pdf
Oncology10.1159/0000121862000594296-301Prognostic Factors in Patients with Metastatic Pancreatic Adenocarcinoma Receiving Systemic ChemotherapyHideki Ueno, Shuichi Okada, Takuji Okusaka, Masafumi Ikedahttps://www.karger.com/Article/Pdf/12186, https://www.karger.com/Article/Pdf/12186
Gynecologic Oncology10.1016/j.ygyno.2007.08.09320081081130-135Prognostic factors in patients treated with taxane-based chemotherapy for recurrent or metastatic endometrial cancer: Proposal for a new prognostic modelG. Mountzios, A. Bamias, Z. Voulgaris, A. Rodolakis, G. Vlahos, G. Gourgoulis, E. Eleftherakis Papaiakovou, A. Giannopouloshttps://api.elsevier.com/content/article/PII:S0090825807007196?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0090825807007196?httpAccept=text/plain
HPB10.1016/j.hpb.2019.10.2140201921S419The impact of neutrophil to lymphocyte ratio as a prognostic factor in Japanese patients with unresectable pancreatic cancer treated with gemcitabine-based chemotherapyYusuke Sasaki, Jojo Hirota, Jun Konnohttps://api.elsevier.com/content/article/PII:S1365182X19328825?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1365182X19328825?httpAccept=text/plain
Annals of Oncology10.1093/annonc/mdu165.104201425ii46Prognostic Factors in Patients with Advanced Pancreatic Cancer Treated with Gemcitabine Chemotherapy: Clinical Characteristics of Long-Term SurvivorsKim Dong Uk, Park SeunJa, Jang Aelee, Bang Seungmin, Cho JaeHeehttps://api.elsevier.com/content/article/PII:S0923753419361319?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0923753419361319?httpAccept=text/plain, http://academic.oup.com/annonc/article-pdf/25/suppl_2/ii46/366862/mdu165.104.pdf
Gastroenterology10.1016/s0016-5085(22)62375-820221627S-1001-S-1002Tu1537: PERI-TREATMENT ANTIBIOTICS IMPROVE SURVIVAL OF PATIENTS WITH METASTATIC PANCREATIC ADENOCARCINOMA TREATED WITH FIRST-LINE GEMCITABINE-BASED CHEMOTHERAPY: A SEER-MEDICARE STUDYDaniel J. Fulop, Haley M. Zylberberg, Y. Linda Wu, Anne Aronson, Arielle J. Labiner, Keith Sigel, Deirdre J. Cohen, Aimee L. Lucashttps://api.elsevier.com/content/article/PII:S0016508522623758?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0016508522623758?httpAccept=text/plain
The Korean Journal of Gastroenterology10.4166/kjg.2014.64.6.3562014646356Prognostic Factors in Patients with Advanced Pancreatic Cancer Treated with Gemcitabine Chemotherapy: Clinical Characteristics of Long-term SurvivorsSung Gyu An, Dong Uk Kim, Geun Am Song, Ae Lee Janghttps://synapse.koreamed.org/DOIx.php?id=10.4166/kjg.2014.64.6.356, https://synapse.koreamed.org/pdf/10.4166/kjg.2014.64.6.356, http://synapse.koreamed.org/DOIx.php?id=10.4166/kjg.2014.64.6.356
Journal of Urology10.1016/j.juro.2013.02.34620131894S782 IDENTIFICATION OF PROGNOSTIC PREDICTORS IN JAPANESE MEN WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER WHO WERE TREATED WITH DOCETAXEL-BASED CHEMOTHERAPYKen-ichi Harada, Hideaki Miyake, Masato Fujisawahttps://api.elsevier.com/content/article/PII:S0022534713006228?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0022534713006228?httpAccept=text/plain, http://www.jurology.com/doi/pdf/10.1016/j.juro.2013.02.346
HPB10.1016/j.hpb.2019.10.2139201921S418Prognostic significance of nutritional and inflammatory markers in patients with unresectable/metastatic (UR-M) pancreatic ductal adenocarcinoma treated with chemotherapyNana Kimura, Kazuto Shibuya, Ryosuke Kobiyama, Takayuki Ando, Shinya Kajiura, Isaku Yoshioka, Ayaka Itoh, Kei Sugano, Ichiro Yasuda, Tsutomu Fujiihttps://api.elsevier.com/content/article/PII:S1365182X19328813?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1365182X19328813?httpAccept=text/plain